Prospective Data Mining of Six Products in the US FDA Adverse Event Reporting System: Disposition of Events Identified and Impact on Product Safety Profiles

Author： Bailey Steven   Singh Ajay   Azadian Robert   Huber Peter   Blum Michael  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.33, Iss.2, 2010-02, pp. : 139-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antimicrobials and the Risk of Torsades de Pointes: The Contribution from Data Mining of the US FDA Adverse Event Reporting System

By Poluzzi Elisabetta  

Drug Safety, Vol. 33, Iss. 4, 2010-04 ,pp. : 303-314

Adis International

Access to resources Recommend Favorite

Data Mining in the US using the Vaccine Adverse Event Reporting System

By Iskander John  

Drug Safety, Vol. 29, Iss. 5, 2006-01 ,pp. : 375-384

Adis International

Access to resources Recommend Favorite

Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database: A Disproportionality Analysis

By Shamloo Behrooz K.  

Drug Safety, Vol. 35, Iss. 6, 2012-06 ,pp. : 507-518

Adis International

Access to resources Recommend Favorite

Drug-versus-Drug Adverse Event Rate Comparisons: A Pilot Study Based on Data from the US FDA Adverse Event Reporting System

By Hochberg Alan M.   Pearson Ronald K.   O'Hara Donald J.   Reisinger Stephanie J.  

Drug Safety, Vol. 32, Iss. 2, 2009-01 ,pp. : 137-146

Adis International

Access to resources Recommend Favorite

An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database

By Wang Hsin-wei  

Drug Safety, Vol. 33, Iss. 12, 2010-12 ,pp. : 1117-1133

Adis International

Access to resources Recommend Favorite